Charles Schwab Investment Management Inc Pulse Biosciences, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $557 Billion
  • Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 172,407 shares of PLSE stock, worth $2.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
172,407
Previous 149,639 15.22%
Holding current value
$2.6 Million
Previous $2.41 Million 8.06%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$14.48 - $19.27 $329,680 - $438,739
22,768 Added 15.22%
172,407 $2.6 Million
Q1 2025

May 09, 2025
BUY
$15.61 - $24.56 $6,759 - $10,634
433 Added 0.29%
149,639 $2.41 Million
Q4 2024

Feb 06, 2025
BUY
$14.56 - $21.08 $15,899 - $23,019
1,092 Added 0.74%
149,206 $2.76 Million
Q3 2024

Nov 12, 2024
BUY
$10.83 - $21.83 $1.06 Million - $2.13 Million
97,565 Added 193.01%
148,114 $2.6 Million
Q2 2024

Aug 12, 2024
BUY
$6.69 - $14.54 $45,853 - $99,657
6,854 Added 15.69%
50,549 $565,000
Q2 2023

Aug 09, 2023
BUY
$3.67 - $8.64 $160,360 - $377,524
43,695 New
43,695 $314,000
Q2 2022

Aug 15, 2022
SELL
$1.48 - $4.28 $45,554 - $131,738
-30,780 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$4.21 - $14.79 $22,371 - $78,594
-5,314 Reduced 14.72%
30,780 $150,000
Q4 2021

Feb 11, 2022
BUY
$14.78 - $24.4 $22,761 - $37,576
1,540 Added 4.46%
36,094 $535,000
Q3 2021

Nov 16, 2021
SELL
$17.25 - $26.63 $4,450 - $6,870
-258 Reduced 0.74%
34,554 $747,000
Q2 2021

Aug 16, 2021
SELL
$16.31 - $23.64 $13,276 - $19,242
-814 Reduced 2.28%
34,812 $571,000
Q1 2021

May 17, 2021
BUY
$22.43 - $44.27 $45,263 - $89,336
2,018 Added 6.0%
35,626 $844,000
Q4 2020

Feb 16, 2021
BUY
$11.66 - $24.5 $28,053 - $58,947
2,406 Added 7.71%
33,608 $802,000
Q3 2020

Nov 13, 2020
SELL
$9.27 - $13.14 $16,055 - $22,758
-1,732 Reduced 5.26%
31,202 $368,000
Q2 2020

Aug 14, 2020
BUY
$6.23 - $13.09 $37,012 - $77,767
5,941 Added 22.01%
32,934 $345,000
Q2 2019

Aug 09, 2019
BUY
$11.11 - $17.34 $20,586 - $32,131
1,853 Added 7.37%
26,993 $357,000
Q1 2019

May 14, 2019
BUY
$11.69 - $19.44 $26,185 - $43,545
2,240 Added 9.78%
25,140 $443,000
Q4 2018

Feb 14, 2019
BUY
$9.08 - $14.34 $27,240 - $43,020
3,000 Added 15.08%
22,900 $263,000
Q3 2018

Nov 13, 2018
BUY
$12.83 - $16.45 $57,735 - $74,025
4,500 Added 29.22%
19,900 $283,000
Q2 2018

Aug 08, 2018
BUY
$14.04 - $20.28 $1,404 - $2,028
100 Added 0.65%
15,400 $234,000
Q3 2017

Nov 13, 2017
BUY
$10.26 - $24.97 $156,978 - $382,041
15,300
15,300 $285,000

Others Institutions Holding PLSE

# of Institutions
90
Shares Held
5.86M
Call Options Held
37.5K
Put Options Held
33.6K
View Full List

About Pulse Biosciences, Inc.

PLSE Quotes by TradingView
  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $561M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email